Literature DB >> 10929077

Increased resistance to mycobacterial infection in the absence of interleukin-10.

M Jacobs1, N Brown, N Allie, R Gulert, B Ryffel.   

Abstract

Interleukin-10 (IL-10) down-regulates T helper type 1 cell and macrophage functions. As IL-10 is induced along with tumour necrosis factor (TNF) and IL-12 in mycobacterial infection, we asked whether endogenous IL-10 plays a role in the antimycobacterial response. We demonstrate here that IL-10-deficient mice eliminate Mycobacterium bovis Calmette-Guérin bacillus faster than wild-type mice. Granulomas are significantly larger, containing more CD-11b- and CD11c-positive antigen-presenting cells and T cells, and the expression of major histocompatibility complex class II and intracellular adhesion molecule-1 is increased. Macrophages in granulomas of IL-10-deficient mice express high levels of TNF, acid phosphatase and inducible nitric oxide synthase (iNOS). Finally, an increased cutaneous delayed-type hypersensitivity reaction to mycobacterial proteins is further evidence of an augmented cell-mediated immune response. In conclusion, the cell-mediated immunity is enhanced in the absence of IL-10, resulting in a robust granuloma response, which accelerates the clearance of mycobacteria. Therefore, endogenous IL-10 attenuates mycobacterial immunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10929077      PMCID: PMC2327039          DOI: 10.1046/j.1365-2567.2000.00053.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  IL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in mice.

Authors:  K J Erb; J Kirman; B Delahunt; W Chen; G Le Gros
Journal:  Immunol Cell Biol       Date:  1998-02       Impact factor: 5.126

2.  Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients.

Authors:  R de Jong; F Altare; I A Haagen; D G Elferink; T Boer; P J van Breda Vriesman; P J Kabel; J M Draaisma; J T van Dissel; F P Kroon; J L Casanova; T H Ottenhoff
Journal:  Science       Date:  1998-05-29       Impact factor: 47.728

3.  Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.

Authors:  F Altare; A Durandy; D Lammas; J F Emile; S Lamhamedi; F Le Deist; P Drysdale; E Jouanguy; R Döffinger; F Bernaudin; O Jeppsson; J A Gollob; E Meinl; A W Segal; A Fischer; D Kumararatne; J L Casanova
Journal:  Science       Date:  1998-05-29       Impact factor: 47.728

Review 4.  The protective immune response to Mycobacterium tuberculosis.

Authors:  A M Cooper; J L Flynn
Journal:  Curr Opin Immunol       Date:  1995-08       Impact factor: 7.486

5.  T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection.

Authors:  P J Murray; L Wang; C Onufryk; R I Tepper; R A Young
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

6.  Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI.

Authors:  G Senaldi; S Yin; C L Shaklee; P F Piguet; T W Mak; T R Ulich
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

7.  The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.

Authors:  A M Cooper; A D Roberts; E R Rhoades; J E Callahan; D M Getzy; I M Orme
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

8.  Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.

Authors:  B Ryffel; B D Car; H Gunn; D Roman; P Hiestand; M J Mihatsch
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

9.  Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis.

Authors:  R J North
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

10.  Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis.

Authors:  A M Cooper; J Magram; J Ferrante; I M Orme
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

View more
  25 in total

1.  An unusual pro-inflammatory role of interleukin-10 induced by arabinosylated lipoarabinomannan in murine peritoneal macrophages.

Authors:  Nivedita Majumder; Ranadhir Dey; Ram Kumar Mathur; Sriparna Datta; Madhumita Maitra; Sanjukta Ghosh; Bhaskar Saha; Subrata Majumdar
Journal:  Glycoconj J       Date:  2006-12       Impact factor: 2.916

Review 2.  Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens.

Authors:  Joshua C Cyktor; Joanne Turner
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

3.  NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp.

Authors:  Matthew D Woolard; Dorothy Hudig; Leslie Tabor; James A Ivey; Jerry W Simecka
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Infection with the helminth Nippostrongylus brasiliensis does not interfere with efficient elimination of Mycobacterium bovis BCG from the lungs of mice.

Authors:  Klaus J Erb; Claudia Trujillo; Mike Fugate; Heidrun Moll
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

5.  Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection.

Authors:  Jonathan M Pitt; Evangelos Stavropoulos; Paul S Redford; Amy M Beebe; Gregory J Bancroft; Douglas B Young; Anne O'Garra
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

6.  Transgenic mice expressing human interleukin-10 in the antigen-presenting cell compartment show increased susceptibility to infection with Mycobacterium avium associated with decreased macrophage effector function and apoptosis.

Authors:  Carl G Feng; Marika C Kullberg; Dragana Jankovic; Allen W Cheever; Patricia Caspar; Robert L Coffman; Alan Sher
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Blocking the receptor for interleukin 10 protects mice from lethal listeriosis.

Authors:  R A Silva; R Appelberg
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

8.  CD36 deficiency attenuates experimental mycobacterial infection.

Authors:  Michael Hawkes; Xiaoming Li; Maryanne Crockett; Angelina Diassiti; Constance Finney; Gundula Min-Oo; W Conrad Liles; Jun Liu; Kevin C Kain
Journal:  BMC Infect Dis       Date:  2010-10-15       Impact factor: 3.090

9.  Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis.

Authors:  M Glória Bonecini-Almeida; John L Ho; Neio Boéchat; Richard C Huard; Sadhana Chitale; Howard Doo; Jiayuan Geng; Lorena Rego; Luiz Claudio Oliveira Lazzarini; Afrânio L Kritski; Warren D Johnson; Timothy A McCaffrey; José R Lapa e Silva
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10.

Authors:  Richard C Huard; Sadhana Chitale; Mary Leung; Luiz Claudio Oliveira Lazzarini; Hongxia Zhu; Elena Shashkina; Suman Laal; Marcus B Conde; Afrânio L Kritski; John T Belisle; Barry N Kreiswirth; José Roberto Lapa e Silva; John L Ho
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.